BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

336 related articles for article (PubMed ID: 16280737)

  • 1. Sexual dysfunction after radical prostatectomy: prevalence, treatments, restricted use of treatments and distress.
    Matthew AG; Goldman A; Trachtenberg J; Robinson J; Horsburgh S; Currie K; Ritvo P
    J Urol; 2005 Dec; 174(6):2105-10. PubMed ID: 16280737
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of erectile dysfunction following therapy for clinically localized prostate cancer: patient reported use and outcomes from the Surveillance, Epidemiology, and End Results Prostate Cancer Outcomes Study.
    Stephenson RA; Mori M; Hsieh YC; Beer TM; Stanford JL; Gilliland FD; Hoffman RM; Potosky AL
    J Urol; 2005 Aug; 174(2):646-50; discussion 650. PubMed ID: 16006930
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Erectile function after radical prostatectomy.
    Mulcahy JJ
    Semin Urol Oncol; 2000 Feb; 18(1):71-5. PubMed ID: 10719936
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Natural and artificial erections in spite of radical, non-nerve-sparing retropubic prostatectomy].
    Hahn C; Haussen RH; Löhr M; Patsialas Ch; Rohde D
    Aktuelle Urol; 2007 Jul; 38(4):305-12. PubMed ID: 17647168
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Update on erectile dysfunction in prostate cancer patients.
    Kendirci M; Bejma J; Hellstrom WJ
    Curr Opin Urol; 2006 May; 16(3):186-95. PubMed ID: 16679857
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact of treatment choice for localized prostate cancer on response to phosphodiesterase inhibitors.
    Lee IH; Sadetsky N; Carroll PR; Sandler HM
    J Urol; 2008 Mar; 179(3):1072-6; discussion 1076. PubMed ID: 18206926
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A prospective evaluation of efficacy and compliance with a multistep treatment approach for erectile dysfunction in patients after non-nerve sparing radical prostatectomy.
    Gontero P; Fontana F; Zitella A; Montorsi F; Frea B
    BJU Int; 2005 Feb; 95(3):359-65. PubMed ID: 15679794
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The use of treatments for erectile dysfunction among survivors of prostate carcinoma.
    Schover LR; Fouladi RT; Warneke CL; Neese L; Klein EA; Zippe C; Kupelian PA
    Cancer; 2002 Dec; 95(11):2397-407. PubMed ID: 12436448
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of medications or devices for erectile dysfunction among long-term prostate cancer treatment survivors: potential influence of sexual motivation and/or indifference.
    Miller DC; Wei JT; Dunn RL; Montie JE; Pimentel H; Sandler HM; McLaughlin PW; Sanda MG
    Urology; 2006 Jul; 68(1):166-71. PubMed ID: 16844457
    [TBL] [Abstract][Full Text] [Related]  

  • 10. After sildenafil: bridging the gap between pharmacologic treatment and satisfying sexual relationships.
    Leiblum SR
    J Clin Psychiatry; 2002; 63 Suppl 5():17-22; discussion 23-5. PubMed ID: 11964137
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quality of life, sexual function and decisional regret at 1 year after surgical treatment for localized prostate cancer.
    Davison BJ; So AI; Goldenberg SL
    BJU Int; 2007 Oct; 100(4):780-5. PubMed ID: 17578466
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Addressing and managing erectile dysfunction after prostatectomy for prostate cancer.
    Albaugh JA
    Urol Nurs; 2010; 30(3):167-177, 166. PubMed ID: 20648854
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Can sexual bother after radical prostatectomy be predicted preoperatively? Findings from a prospective national study of the relation between sexual function, activity and bother.
    Steinsvik EA; Axcrona K; Dahl AA; Eri LM; Stensvold A; Fosså SD
    BJU Int; 2012 May; 109(9):1366-74. PubMed ID: 21999333
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The psychosocial aspects of sexual recovery after prostate cancer treatment.
    Wittmann D; Northouse L; Foley S; Gilbert S; Wood DP; Balon R; Montie JE
    Int J Impot Res; 2009; 21(2):99-106. PubMed ID: 19158798
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sexual dysfunction following radical prostatectomy.
    Benson CR; Serefoglu EC; Hellstrom WJ
    J Androl; 2012; 33(6):1143-54. PubMed ID: 22744864
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early combination therapy: intracavernosal injections and sildenafil following radical prostatectomy increases sexual activity and the return of natural erections.
    Nandipati K; Raina R; Agarwal A; Zippe CD
    Int J Impot Res; 2006; 18(5):446-51. PubMed ID: 16482200
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combination therapy: medicated urethral system for erection enhances sexual satisfaction in sildenafil citrate failure following nerve-sparing radical prostatectomy.
    Raina R; Nandipati KC; Agarwal A; Mansour D; Kaelber DC; Zippe CD
    J Androl; 2005; 26(6):757-60. PubMed ID: 16291971
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acetyl-L-carnitine plus propionyl-L-carnitine improve efficacy of sildenafil in treatment of erectile dysfunction after bilateral nerve-sparing radical retropubic prostatectomy.
    Cavallini G; Modenini F; Vitali G; Koverech A
    Urology; 2005 Nov; 66(5):1080-5. PubMed ID: 16286128
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acceptance of and discontinuation rate from erectile dysfunction oral treatment in patients following bilateral nerve-sparing radical prostatectomy.
    Salonia A; Gallina A; Zanni G; Briganti A; Dehò F; Saccà A; Suardi N; Barbieri L; Guazzoni G; Rigatti P; Montorsi F
    Eur Urol; 2008 Mar; 53(3):564-70. PubMed ID: 17761385
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management of erectile dysfunction after radical prostatectomy.
    Hall MC
    Semin Urol Oncol; 1995 Aug; 13(3):215-23. PubMed ID: 8521135
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.